Protective mechanisms of protocatechuic acid against doxorubicin-induced nephrotoxicity in rat model

J Basic Clin Physiol Pharmacol. 2019 Jul 8;30(4). doi: 10.1515/jbcpp-2018-0191.

Abstract

Background Doxorubicin (DOX) induces toxicity in many tissues/organs, including the heart, kidney and so on. This study was designed to evaluate the modulatory effects of protocatechuic acid (PCA) against DOX-induced nephrotoxicity in rats. Animals were randomly grouped into five groups. Methods Group 1 served as the normal control (CTR). A single dose of DOX at 20 mg/kg was administered intraperitoneally (i.p.) to animals in Group 2. Groups 3 and 4 were pretreated with PCA for 5 days (doses of 10 and 20 mg/kg body weight, respectively) after which DOX was injected (PCA-10 + DOX and PCA-20 + DOX). Group 5 received PCA only at a dose of 20 mg/kg body weight (PCA-20). Results The results revealed significant elevations (p < 0.05) in malondialdehyde content, expressions of inducible nitric oxide (iNOS) and cyclooxygenase-2 (COX2) in the kidney. Likewise, increased serum levels of creatinine and urea of DOX group were observed. A significant decrease (p < 0.05) in glutathione (GSH) level and antioxidant enzymes: superoxide dismutase (SOD), catalase (CAT), glutathione peroxidase (GPx) and glutathione s- transferase (GST) activities in the kidney were observed compared with the control. Pretreatment with PCA (10 and 20 mg/kg, p.o.) for 5 days prior to the i.p. injection of DOX reduced MDA levels, modulated iNOS and COX2 activities and improved kidney function markers as well as oxidative stress parameters. Findings from the histopathology studies confirms the protective effects of PCA on DOX-induced damage on the kidney cells. Conclusions This study has demonstrated the anti-inflammatory and antioxidative properties of PCA, which could be part of its possible protective mechanisms against nephrotoxicity induced by DOX.

Keywords: antioxidant; doxorubicin; nephrotoxicity; oxidative stress; protocatechuic acid.

MeSH terms

  • Animals
  • Antioxidants / pharmacology
  • Biomarkers / metabolism
  • Creatinine / metabolism
  • Disease Models, Animal
  • Doxorubicin / adverse effects*
  • Glutathione / metabolism
  • Glutathione Peroxidase / metabolism
  • Hydroxybenzoates / pharmacology*
  • Kidney / drug effects*
  • Kidney Diseases / chemically induced*
  • Kidney Diseases / drug therapy*
  • Malondialdehyde / metabolism
  • Nitric Oxide / metabolism
  • Oxidative Stress / drug effects
  • Protective Agents / pharmacology*
  • Rats
  • Rats, Wistar
  • Superoxide Dismutase / metabolism

Substances

  • Antioxidants
  • Biomarkers
  • Hydroxybenzoates
  • Protective Agents
  • Nitric Oxide
  • protocatechuic acid
  • Malondialdehyde
  • Doxorubicin
  • Creatinine
  • Glutathione Peroxidase
  • Superoxide Dismutase
  • Glutathione